English
  1. Home
  2. Stocks
  3. Medicameq Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Medicamen Biotech Share Price Medicamen Biotech

    Small Cap
    ₹499.85
    -19.65 (-3.78%)
    09 May, 2024 18:34 BSE: 531146 NSE: MEDICAMEQISIN: INE646B01010

    Start SIP in Medicamen Biotech

    Start SIP

    Medicamen Biotech Performance

    Day Range

    • Low 493
    • High 535
    ₹ 499

    52 Week Range

    • Low 355
    • High 845
    ₹ 499
    • Open Price521
    • Previous Close520
    • Volume21154

    Medicamen Biotech Share Price

    • Over 1 Month +14.68%
    • Over 3 Month -3.82%
    • Over 6 Month -25.31%
    • Over 1 Year -27.54%

    Medicamen Biotech Key Statistics

    P/E Ratio 56.6
    PEG Ratio -3.1
    Market Cap Cr 636
    Price to Book Ratio 3.3
    EPS 11.9
    Dividend 0.2
    Relative Strength Index 54.67
    Money Flow Index 85.76
    MACD Signal 21.18
    Average True Range 33.29
    Medicamen Biotech Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 44434137
    Operating Expenses Qtr Cr 39373330
    Operating Profit Qtr Cr 6677
    Depreciation Qtr Cr 2222
    Interest Qtr Cr 1111
    Tax Qtr Cr 1111
    Net Profit Qtr Cr 3344
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 140
    Operating Expenses Annual Cr 114
    Operating Profit Annual in Cr 24
    Depreciation Cr 6
    Interest Annual Cr 3
    Tax Annual Cr 2
    Net Profit Annual Cr 15
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr -3
    Cash from Investing Activity Annual Cr -8
    Cash from Financing Annual Activity Cr 28
    Net Cash Flow Annual Cr 17
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 193
    Fixed Assets Annual Cr 92
    Total Non Current Assets Annual Cr 119
    Total Current Assets Annual Cr 158
    Total Assets Annual Cr 277
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 152
    ROE Annual % 8
    ROCE Annual % 10
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 19
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 47444239
    Operating Expenses Qtr Cr 42393532
    Operating Profit Qtr Cr 5576
    Depreciation Qtr Cr 2222
    Interest Qtr Cr 1111
    Tax Qtr Cr 1111
    Net Profit Qtr Cr 2144
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 143
    Operating Expenses Annual Cr 117
    Operating Profit Annual in Cr 24
    Depreciation Cr 6
    Interest Annual Cr 3
    Tax Annual Cr 2
    Net Profit Annual Cr 15
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr -6
    Cash from Investing Activity Annual Cr -6
    Cash from Financing Annual Activity Cr 29
    Net Cash Flow Annual Cr 17
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 191
    Fixed Assets Annual Cr 93
    Total Non Current Assets Annual Cr 115
    Total Current Assets Annual Cr 163
    Total Assets Annual Cr 279
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 151
    ROE Annual % 8
    ROCE Annual % 10
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 19
    Sign Up to Know More
    Invest in Medicamen Biotech

    Medicamen Biotech Technicals

    EMA & SMA

    Current Price
    ₹499.85
    -19.65 (-3.78%)
    pointer
    • Bullish Moving Average
    • ___
    • 6
    • Bearish Moving Average
    • ___
    • 10
    • 20 Day
    • ₹488.66
    • 50 Day
    • ₹476.40
    • 100 Day
    • ₹506.14
    • 200 Day
    • ₹565.74
    • 20 Day
    • ₹474.39
    • 50 Day
    • ₹451.35
    • 100 Day
    • ₹503.01
    • 200 Day
    • ₹594.97

    Medicamen Biotech Resistance and Support

    PIVOT
    ₹509.27
    Resistance
    First Resistance 525.53
    Second Resistance 551.22
    Third Resistance 567.48
    RSI 54.67
    MFI 85.76
    MACD Single Line 21.18
    MACD 25.56
    Support
    First Resistance 483.58
    Second Resistance 467.32
    Third Resistance 441.63

    Medicamen Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 9,906 552,854 55.81
    Week 30,666 1,521,667 49.62
    1 Month 74,240 3,003,004 40.45
    6 Month 43,119 2,335,339 54.16

    Medicamen Biotech Result Highlights

    Medicamen Biotech Synopsis

    NSE-Medical-Generic Drugs

    Medicamen Biotec is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 137.88 Cr. and Equity Capital is Rs. 12.65 Cr. for the Year ended 31/03/2023. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
    Market Cap 638
    Sales 165
    Shares in Float 0.72
    No of funds 6
    Yield 0.21
    Book Value 3.41
    U/D Vol ratio 1.1
    LTDebt / Equity 3
    Alpha -0.29
    Beta 1.3

    Medicamen Biotech

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 43.21%43.21%43.21%43.21%
    Mutual Funds
    Foreign Portfolio Investors 0.12%0.22%0.22%0.16%
    Individual Investors 31.96%31.9%31.81%31.43%
    Others 24.71%24.67%24.76%25.2%

    Medicamen Biotech Management

    Name Designation
    Mr. Rahul Bishnoi Chairman
    Dr. Vimal Kumar Shrawat Non Executive Director
    Mr. Sanjay Bansal Non Executive Director
    Mr. Suresh Kumar Singh Non Executive Director
    Mr. Ashwani Kumar Sharma Non Executive Director
    Mr. Harish Pande Independent Director
    Ms. Sangeeta Bishnoi Independent Director
    Dr. Ravi Kumar Bansal Independent Director
    Mr. Arun Kumar Independent Director
    Ms. Sumita Dwivedi Independent Director

    Medicamen Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Medicamen Biotech Corporate Action

    Date Purpose Remarks
    2024-02-12 Quarterly Results
    2023-11-10 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-29 Audited Results & Final Dividend
    2023-02-10 Quarterly Results

    Medicamen Biotech MF Shareholding

    Name Amount(cr)

    Medicamen Biotech FAQs

    What is Share Price of Medicamen Biotech ?

    Medicamen Biotech share price is ₹499 As on 09 May, 2024 | 18:20

    What is the Market Cap of Medicamen Biotech ?

    The Market Cap of Medicamen Biotech is ₹635.5 Cr As on 09 May, 2024 | 18:20

    What is the P/E ratio of Medicamen Biotech ?

    The P/E ratio of Medicamen Biotech is 56.6 As on 09 May, 2024 | 18:20

    What is the PB ratio of Medicamen Biotech ?

    The PB ratio of Medicamen Biotech is 3.3 As on 09 May, 2024 | 18:20

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.